Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniel K. Noland"'
Autor:
Michael Price, Hung S. Luu, Jennifer Fuchs, Michael E. Sebert, Ami Waters, Erin McElvania, Laura M. Filkins, Michelle S. Hsiang, Leigh Anna Stubbs, Daniel K. Noland
Publikováno v:
Journal of the Pediatric Infectious Diseases Society
In non-endemic settings, transfusion-transmitted malaria (TTM) is rare but potentially fatal and becoming more common with globalization. We present two pediatric cases that demonstrate donor screening using questionnaires is subject to error and tha
Autor:
David M. Notrica, Cynthia Greenwell, Nadja Apelt, R. Todd Maxson, James W. Eubanks, Jefferson Tweed, Daniel K. Noland, Nilda M. Garcia, Adam C. Alder
Publikováno v:
Journal of Pediatric Surgery. 54:345-349
Massive transfusion protocols (MTPs) are considered valuable in pediatric trauma. Important questions regarding the survival benefit and optimal blood component ratio remain unknown.The study time frame was January 2007 through December 2013 five Lev
Autor:
Jessica Jones, Laura Petitti, Erik Spaepen, Zhan Ye, Hung S. Luu, Joel N. Kniep, Jessica Poisson, Daniel K. Noland, Daniel Millar, Chelsea Hayes, Elisabeth Maurer-Spurej, Ellen Klapper
Publikováno v:
Transfusion.
BACKGROUND The microparticle content (MP%) of apheresis platelets-a marker of platelet activation-is influenced by donor factors and by external stressors during collection and storage. This study assessed the impact of apheresis technology and other
Autor:
Benjamin Greenberg, Daniel K. Noland
Publikováno v:
Neurology: Clinical Practice. 8:327-330
BackgroundWe sought to review safety and efficacy of therapeutic plasma exchange (TPE) in a cohort of pediatric patients with transverse myelitis.MethodsBilling data of all plasma exchanges performed at our tertiary care pediatric hospital between Au
Autor:
Sara S. Qureshi, Kathryn C King, Allen DeSena, Benjamin Greenberg, Donna Graves, Lauren Phillips, Daniel K. Noland, Karen Matevosyan
Publikováno v:
Journal of Clinical Apheresis. 30:212-216
Introduction: Anti-N-methyl-d-aspartate (NMDA) receptor antibody encephalitis is an increasingly recognized form of autoimmune encephalitis. Conventional treatments include therapies such as corticosteroids, intravenous immunoglobulin (IVIg), and/or
Autor:
Allen D, DeSena, Daniel K, Noland, Karen, Matevosyan, Kathryn, King, Lauren, Phillips, Sara S, Qureshi, Benjamin M, Greenberg, Donna, Graves
Publikováno v:
Journal of clinical apheresis. 30(4)
Anti-N-methyl-d-aspartate (NMDA) receptor antibody encephalitis is an increasingly recognized form of autoimmune encephalitis. Conventional treatments include therapies such as corticosteroids, intravenous immunoglobulin (IVIg), and/or therapeutic pl